Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
R

RIME

Nasdaq

Algorhythm Holdings, Inc.

Latest disclosureOctober 7, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

4 purchases · 0 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 16

Limited filing history
All16Buying4Selling0Other12
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

12 of 16 trades · November 20, 2025 – September 15, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 12 trades on this page.

Award disclosed

Leticia Adriana Raele

INTERIM CFO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 15, 2026Filed October 7, 2026SEC filing
Award disclosed

Andrew Little Thompson

CEO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 15, 2026Filed October 5, 2026SEC filing
Award disclosed

Ryan Jay Smith

COO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 15, 2026Filed October 5, 2026SEC filing
Other activity disclosed

Alex Andre

CFO & General Counsel

Common Stock

Value context
Not established
Reported price
$0 reported · see filing
Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Traded May 11, 2026Filed May 13, 2026SEC filing
Other activity disclosed

Alex Andre

CFO & General Counsel

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not established
Reported price
$0 reported · see filing
Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Traded May 11, 2026Filed May 13, 2026SEC filing
Award disclosed

Alex Andre

CFO & General Counsel

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 11, 2026Filed May 13, 2026SEC filing
Award disclosed

Scott Thorn

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded November 20, 2025Filed March 31, 2026SEC filing
Award disclosed

Scott Thorn

Director

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded November 20, 2025Filed March 31, 2026SEC filing
Award disclosed

Bernardo Melo

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded November 20, 2025Filed March 31, 2026SEC filing
Award disclosed

Bernardo Melo

Director

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded November 20, 2025Filed March 31, 2026SEC filing
Award disclosed

Harvey Judkowitz

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded November 20, 2025Filed March 31, 2026SEC filing
Award disclosed

Harvey Judkowitz

Director

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded November 20, 2025Filed March 31, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
INTERIM CFOStock Option (right to buy)Grant or awardDerivative units1,144,552Award · no purchase priceNon-cash awardSep 15Filed Oct 7 · 22d laterSEC filing
CEOCommon StockGrant or award2,119,542Award · no purchase priceNon-cash awardSep 15Filed Oct 5 · 20d laterSEC filing
COOCommon StockGrant or award2,119,542Award · no purchase priceNon-cash awardSep 15Filed Oct 5 · 20d laterSEC filing
CFO & General CounselCommon StockDisposition to issuer23,818$0 reported · see filingNot establishedMay 11Filed May 13 · 2d laterSEC filing
CFO & General CounselStock Option (right to buy)Disposition to issuerDerivative units23,818$0 reported · see filingNot establishedMay 11Filed May 13 · 2d laterSEC filing
CFO & General CounselStock Option (right to buy)Grant or awardDerivative units47,636Award · no purchase priceNon-cash awardMay 11Filed May 13 · 2d laterSEC filing
DirectorCommon StockGrant or award19,532Award · no purchase priceNon-cash awardNov 20Filed Mar 31 · 131d laterSEC filing
DirectorStock Option (right to buy)Grant or awardDerivative units39,063Award · no purchase priceNon-cash awardNov 20Filed Mar 31 · 131d laterSEC filing
DirectorCommon StockGrant or award19,532Award · no purchase priceNon-cash awardNov 20Filed Mar 31 · 131d laterSEC filing
DirectorStock Option (right to buy)Grant or awardDerivative units39,063Award · no purchase priceNon-cash awardNov 20Filed Mar 31 · 131d laterSEC filing
DirectorCommon StockGrant or award19,532Award · no purchase priceNon-cash awardNov 20Filed Mar 31 · 131d laterSEC filing
DirectorStock Option (right to buy)Grant or awardDerivative units19,532Award · no purchase priceNon-cash awardNov 20Filed Mar 31 · 131d laterSEC filing

Congress transactions 0

All Congress filings
No disclosed congressional trades for RIME in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0000923601
Latest public acceptance
Oct 7, 2026, 10:20 PM UTC
Score calculated
Oct 8, 2026, 12:04 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.